IGSF11 Protein (AA 23-241) (Fc Tag)
-
- Antigène Voir toutes IGSF11 Protéines
- IGSF11 (Immunoglobulin Superfamily, Member 11 (IGSF11))
- Type de proteíne
- Recombinant
- Activité biologique
- Active
- Attributs du protein
- AA 23-241
-
Origine
- Humain
-
Source
- HEK-293 Cells
- Purification/Conjugué
- Cette IGSF11 protéine est marqué à la Fc Tag.
- Pureté
- >95 % as determined by SDS-PAGE.
- niveau d'endotoxine
- Less than 1.0 EU per μg by the LAL method.
- Top Product
- Discover our top product IGSF11 Protéine
-
-
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Buffer
- Tris with Glycine, Arginine and NaCl, pH 7.5
- Stock
- -20 °C
-
- Antigène
- IGSF11 (Immunoglobulin Superfamily, Member 11 (IGSF11))
- Autre désignation
- VSIG3 (IGSF11 Produits)
- Synonymes
- sc:d812 Protein, seurat Protein, BT-IgSF Protein, CT119 Protein, CXADRL1 Protein, Igsf13 Protein, VSIG3 Protein, 1700025L02Rik Protein, immunoglobulin superfamily member 11 Protein, immunoglobulin superfamily member 11 L homeolog Protein, immunoglobulin superfamily, member 11 Protein, IGSF11 Protein, igsf11 Protein, igsf11.L Protein, Igsf11 Protein
- Sujet
- VSIG3, also known as IGSF11, BT-IgSF, and CLMP, is a homophilic adhesion molecule that preferentially expressed in the brain. The function of VSIG3 is to stimulate cell growth through homophilic interactions. In clinical, the VSIG3 has been reported to as a novel target for cancer immunotherapy of gastrointestinal and hepatocellular carcinomas. In addition, VSIG-3 is also a ligand of B7 family member VISTA/PD-1H and inhibits human T-cell functions through a novel VSIG-3/VISTA pathway. VSIG-3/VISTA co-inhibitory pathway may provide new strategies for the treatment of human cancers and autoimmune disorders.
- Poids moléculaire
- 49.7 kDa
- NCBI Accession
- NP_001015887
-